<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03647046</url>
  </required_header>
  <id_info>
    <org_study_id>72749</org_study_id>
    <nct_id>NCT03647046</nct_id>
  </id_info>
  <brief_title>Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus</brief_title>
  <official_title>Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ovitz Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Sight</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to examine the effects of custom front-surface wavefront correction
      on visual performance, and on neutralization of higher order aberrations, in patients wearing
      a scleral lens device. The investigators will study patients with keratoconus, the most
      common type of corneal ectasia, who have already been fitted with the BostonSight BSS (Boston
      Sight Scleral) for improved visual function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a single center, double-masked collection of data taking place at the
      Flaum Eye Institute. Informed consent will be obtained from all subjects after a thorough
      explanation of the nature and possible risks of the study. Flaum Eye Institute electronic
      health records of existing patients will first be screened by an optometrist or
      ophthalmologist to verify that they do not fall under the exclusion criteria. Some study
      communication regarding scheduling will be done over the phone or email. The screening will
      be similar to a standard eye exam (without eye dilation) and will include a slit lamp
      examination as well as visual acuity and basic vision evaluation.

      The study eye will be chosen based on inclusion criteria; if both eyes qualify, the eye with
      worse best corrected acuity will be chosen. A new lens will be manufactured for the subject
      after the screening visit and will be given to the subject during the following study visit.
      This is done to ensure fully neutralized spherical refractive effort and positional
      stability. If screening evaluation reveals that the current lens does not fully neutralize
      spherical refractive error or that the current lens is not positionally stable, a baseline
      lens will be manufactured that corrects this. The subject will be allowed to keep the old
      lens if he or she so chooses.

      At the second visit, the patient's vision and fit will be evaluated with the optimized
      baseline BSS lens. Visual acuity and device fit will be evaluated and recorded. If the BSS
      device fit is still not optimized, then a new device will be made , and the second visit
      evaluation will be rescheduled. Once the baseline lens design is determined to be
      satisfactory, the patient will have their wavefront aberration measured with a wavefront
      sensor. Investigators will dilate the pupil pharmacologically with phenylephrine (2.5%) and
      tropicamide (1%) and take wavefront measurements of the optical aberrations of the subject's
      eye wearing the baseline lens using a portable, non-invasive wavefront analyzer designed to
      measure highly aberrated eyes (Ovitz, P10/EyeProfiler). The investigators will then design
      and manufacture a study lens that is identical in design to the baseline BostonSight BSS lens
      except for a custom front surface designed to neutralize the optical aberrations measured
      with the wavefront analyzer. This HOA-optimized lens will be created prior to the third
      visit.

      At the third visit the patient's vision and fit will be evaluated with the new HOA-optimized
      lens. A designated study team member will measure visual acuity and over-refraction of the
      patient. If an adjustment is needed for the lens, then a new device will be made, and the
      third visit evaluation will be rescheduled.

      Once well-fitting baseline and HOA-optimized test lenses are established, both lenses will be
      remade and presented to the evaluator designated study team member in charge of evaluation
      and subject together in a masked fashion. During a fourth visit, the patient's vision will be
      extensively evaluated using standard non-invasive optometric measurements with each of the
      two lenses. First the patient will undergo a basic evaluation with each lens to ensure that
      the fit is correct. The patient will then undergo basic visual acuity; high and low contrast
      visual acuity, contrast sensitivity, and subjective vision scoring with each lens. The
      subject's wavefront aberration will also be measured again with each lens.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 8, 2018</start_date>
  <completion_date type="Actual">January 20, 2020</completion_date>
  <primary_completion_date type="Actual">January 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Normal Vision</measure>
    <time_frame>30 minutes</time_frame>
    <description>Vision will be tested using the Basic Snellen Visual Acuity test and normal vision will be defined as 20/20.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Customized Scleral Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A customized scleral lens will be compared with a non-customized scleral lens in subjects with Keratoconus through vision tests.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Customized Scleral Lens</intervention_name>
    <description>A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.</description>
    <arm_group_label>Customized Scleral Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        A person will be included in the study if he/she:

          -  Is 18 years or older and has full legal capacity to volunteer.

          -  Has been diagnosed with Keratoconus;

          -  Has no other active ocular disease;

          -  Is currently wearing the BostonSight BSS in at least one eye ;

          -  Has non-spherical BostonSight BSS haptic design in the study eye;

          -  Has 20/400 or better best corrected visual acuity with pinhole 20/60 or better in the
             study eye;

          -  Is not pregnant or nursing;

          -  Has voluntarily agreed to participate in the study by signing the statement of
             informed consent;

        A person will be excluded from the study if he/she:

          -  Is under the age of 18;

          -  Has best corrected visual acuity outside 20/400;

          -  Pregnant or nursing at the time of enrollment in the study;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Flaum Eye Institute, University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2018</study_first_posted>
  <results_first_submitted>February 11, 2020</results_first_submitted>
  <results_first_submitted_qc>February 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2020</results_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Tara Vaz</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Keratoconus, scleral lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 21, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT03647046/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 27, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT03647046/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Customized Scleral Lens</title>
          <description>A customized scleral lens will be compared with a non-customized scleral lens in subjects with Keratoconus through vision tests.
Customized Scleral Lens: A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Customized Scleral Lens</title>
          <description>A customized scleral lens will be compared with a non-customized scleral lens in subjects with Keratoconus through vision tests.
Customized Scleral Lens: A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.9" lower_limit="20" upper_limit="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Keratoconus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Normal Vision</title>
        <description>Vision will be tested using the Basic Snellen Visual Acuity test and normal vision will be defined as 20/20.</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Customized Scleral Lens</title>
            <description>A customized scleral lens will be compared with a non-customized scleral lens in subjects with Keratoconus through vision tests.
Customized Scleral Lens: A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Normal Vision</title>
          <description>Vision will be tested using the Basic Snellen Visual Acuity test and normal vision will be defined as 20/20.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Customized Scleral Lens</title>
          <description>A customized scleral lens will be compared with a non-customized scleral lens in subjects with Keratoconus through vision tests.
Customized Scleral Lens: A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Coordinator</name_or_title>
      <organization>University of Rochester</organization>
      <phone>(585) 276-6922</phone>
      <email>keratoconusstudy@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

